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Abstract
Since available structures of native bc1 complexes show a vacant Qo-site, occupancy by substrate and product must be investigated by
kinetic and spectroscopic approaches. In this brief review, we discuss recent advances using these approaches that throw new light on the
mechanism. The rate-limiting reaction is the first electron transfer after formation of the enzyme–substrate complex at the Qo-site. This is
formed by binding of both ubiquinol (QH2) and the dissociated oxidized iron–sulfur protein (ISPox). A binding constant of f 14 can be
estimated from the displacement of Em or pK for quinone or ISPox, respectively. The binding likely involves a hydrogen bond, through which
a proton-coupled electron transfer occurs. An enzyme–product complex is also formed at the Qo-site, in which ubiquinone (Q) hydrogen
bonds with the reduced ISP (ISPH). The complex has been characterized in ESEEM experiments, which detect a histidine ligand, likely His-
161 of ISP (in mitochondrial numbering), with a configuration similar to that in the complex of ISPH with stigmatellin. This special
configuration is lost on binding of myxothiazol. Formation of the H-bond has been explored through the redox dependence of cytochrome c
oxidation. We confirm previous reports of a decrease in Em of ISP on addition of myxothiazol, and show that this change can be detected
kinetically. We suggest that the myxothiazol-induced change reflects loss of the interaction of ISPH with Q, and that the change in Em reflects
a binding constant of f 4. We discuss previous data in the light of this new hypothesis, and suggest that the native structure might involve a
less than optimal configuration that lowers the binding energy of complexes formed at the Qo-site so as to favor dissociation. We also discuss
recent results from studies of the bypass reactions at the site, which lead to superoxide (SO) production under aerobic conditions, and provide
additional information about intermediate states.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The availability of structures for the complete bc1 com-
plex has stimulated a renewed interest in these central
components of the main energy transduction pathways
[1–7]. The structures have been invaluable in providing
new mechanistic insights, and, quite gratifyingly, they con-
firmed features expected from an extensive prior period of
research on the biochemistry and mechanism of the com-
plex, and from structural prediction.
One surprise from the structures was the disposition of
the extrinsic head domain of the Rieske iron–sulfur protein
(ISP), found in at least eight different positions in structures
reported to date [2–7], and the recognition that in none of
these positions would a static structure be competent in
catalysis [3]. The explanation in terms of a requirement for
movement between catalytic interfaces on cytochrome (cyt)
b and cyt c1 [3,8–10] is now generally accepted. The
structures have encouraged new studies of mechanistic
aspects. Much of this work has been directed to under-
standing the role of the ISP movement [11–16]. Movement
of the ISP during catalysis has also focused attention on the
role of this group as a substrate, and its participation in
formation of the intermediate complexes at the Qo-site of the
bc1 complex [8–10,16–20]. The structures have provided a
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detailed picture of the binding of inhibitors at the site, but no
direct information on the configuration of the substrate
quinol, intermediate semiquinone or product quinone [1–
7]. The structures showed weaker electron density for the
extrinsic domain of the ISP than for the remainder of the
protein, and quantitative analysis of this phenomenon gave
ranges for the binding constants for ISP at the cyt b interface
(ISPB) in the crystals, all of which (with the exception of the
stigmatellin- or UHDBT-containing complexes) were
around 1 or less [9]. Larger values for binding constants
involving transient states could be derived from thermody-
namic and kinetic studies of the partial reactions leading to
turnover of the Qo-site [18].
Several aspects of the mechanism are controversial,
particularly the question of whether or not the reaction
requires participation of two quinones in double-occupancy
[10,17,21–23]. As in the past, the heat of controversy is
inversely proportional to the hardness of the data, which in
this case reflects the lack of information on occupancy by
the quinone species under functional conditions. In this
paper, we review the evidence available on the nature of
the liganding between the ISP and different occupants of
Qo-site.
1.1. Substrate binding
The change in rate of a reaction on varying substrate
concentration is determined by the consequent change in
concentration of the enzyme–substrate (ES)-complex.
Crofts and colleagues have used this to explore the binding
constants associated with formation of the ES-complex at
the Qo-site. From the movement of ISP seen in the struc-
tures, it is clear that two substrates are involved—QH2 and
ISPox, likely in its dissociated form [18–20]. The concen-
tration of these could be varied independently by redox or
pH titration, respectively. Formation of the ES-complex was
reflected in the differential binding of quinol when the ISP is
oxidized, and in the preferential binding of the dissociated
form of ISPox. By observing the displacement of the kineti-
cally determined values of Em (for the Q/QH2 couple) or pK
(of ISPox) from the values in the absence of interaction, we
could estimate relative binding constants for QH2 and ISPox,
both of which showed values f 14 [10,17,18,20].
1.2. Kinetics of QH2 oxidation
The bifurcated reaction delivers the two electrons from
QH2 to two separate chains. From detailed kinetic studies
following flash-activation in Rb. sphaeroides, including the
temperature dependence of partial reactions, Hong et al. [18]
showed that the oxidation of bound QH2 was rate-determin-
ing, and the partial reaction with the highest activation
energy. The rate was dependent on the driving force for
the first electron transfer to ISPox, since mutations leading to
changes in Em or pK of ISP gave rise to changes in rate
consistent with Marcus theory [18,19]. However, the rate
appears not to depend on the Em for the acceptor of the
second electron, heme bL. From this it seems clear that the
first electron transfer is the limiting step. At saturating
substrate concentrations and ambient temperature, the turn-
over time is about 0.75 ms. From the structures and the
relatively short reaction pathway, the slow rate of the
reaction is anomalous, but can be explained in terms of a
coupled proton and electron transfer. It seems likely that this
is along the H-bond between QH2 and His-161 of the
oxidized ISP. If so, the energy of activation would be given
by the sum of positive contributions from two improbable
processes:
E:bL.QH2.ISPox f
DGproton
E:bL.QH
.HþISPox f
DG#
electron
ES#
! E:bL.QH  :ISPH
However, because H + transfer along H-bonds is very rapid,
the constraints of Marcus theory might apply only to the
electron transfer part. Crofts et al. [24] suggested that the
treatment of Moser et al. [25] could be adapted by including
an additional Bro¨nsted term, given by the difference
between the pK values of the participating groups, QH2
(pK>11.3) and ISPox (pKf 7.6), to describe the probability
of proton transfer:
log10k ¼ 13 0:6ðR 3:6Þ  3:1ðDGjþ kÞ2=k
 ðpKQH2  pKISPoxÞ:
This gave a good fit to the observed rates using values for k
and intrinsic rate constant in the range expected for electron
transfer over the f 7-A˚ distance of the bridging histidine. It
should be noted that this treatment is appropriate only if the
form of the ISPox participating in the reaction is the
dissociated species, so that the reaction is constrained to a
proton-coupled electron transfer.
1.3. The quinone–ISPH complex
Binding of Q to the reduced ISP (ISPH) can be studied
through the effects on the rhombic EPR spectrum
[21,22,26,27]. There are changes throughout but those in
the gx region are most prominent, becoming sharper on
interaction with quinone ( gx = 1.80), stigmatellin or
UHDBT ( gx= 1.78). Bertrand et al. [28] and Link [29] have
previously discussed the EPR spectroscopic characteristics
of reduced Rieske-type centers, and noted the changes in
rhombicity associated with the modification of energies for
electron spin transitions with magnetic field along the gx, gy
and gz directions under different conditions of ligation.
Increasing differences between gx and gy reflect increas-
ing asymmetry of the cluster. Interestingly, the variation in
rhombicity induced in the ISP of the bc1 complexes of Rb.
sphaeroides and Rb. capsulatus by mutation, or by variation
in occupancy of the Qo-site, shows a similar pattern (Fig. 1).
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An alternative approach is to score the rhombicity
according to an R factor, comparing the anisotropies of
gy gz and gy gx in the EPR spectrum [29,30]:
RzðxÞ ¼
300ðgy  gxðzÞÞ
ð2gzðxÞ  gy  gxðzÞÞ ½%	
Using this approach, Samoilova et al. [31] noted that the
quinone complex and the stigmatellin complex had a similar
rhombicity, with Rz <Rx, which was different from the
Rz>Rx seen after binding of myxothiazol, when the mobile
domain is rotated away from the Qo-site, and has no contact
with the occupant. Pulsed EPR experiments (1D and 2D
ESEEM) were used to investigate the interaction between
the paramagnetic reduced Rieske cluster and the nuclear
spins of the immediate environment. Because the spectrum
is rhombic, the different orientations of the cluster could be
probed by selection of gx, gy or gz lines. It was found that the
complex between quinone and ISPH, detected through
hyperfine and quadrupole couplings with 14Ny from one
of the histidine ligands, was similar to that seen with
stigmatellin. From the structures, the histidine involved
was likely His-161 (in chicken numbering, 3), which forms
a H-bond with stigmatellin through NqH. This strongly
supports the suggestion that ISPH forms a similar H-bond
with quinone [9,10,17,21,22].
1.4. Kinetic aspects
From the redox dependence of the appearance of the gx
line, Ding et al. [21,22] concluded that Q and QH2
interacted with the site (when ISP is reduced) with a
similar binding coefficient. They ascribed a gx = 1.783 line,
seen after partial extraction of quinone, to interaction of a
tightly bound species with ISPH, and the gx= 1.80 signal to
further interaction with an exchangeable quinone, to give a
double-occupancy model. However, from the movement of
the ISP, it is clear that its interaction cannot reflect any
complex longer lived than the turnover time of the high
potential chain [10]. From the kinetics of reduction of cyt
c1 under conditions in which a fraction of the ISPH is
initially tied up in the gx = 1.80 complex (Fig. 2), Crofts et
al. [9] suggested limits for the release rate, with t1 2=
between < 30 As and 3 ms. Analysis of the kinetics is
complicated by the fact that the observed oxidation repre-
sents only about half of the total oxidizing equivalents
Fig. 2. Kinetic traces showing cyt ct (c1 plus c2) oxidation (measured from DA551DA542) following flash activation of chromatophores poised with the
ubiquinone pool f 30% reduced (left, f 100 mV), in the presence and absence of myxothiazol, as indicated. The difference kinetics (right) show the phase of
oxidation slowed in the presence of myxothiazol, due to more rapid reduction of cyt c1 by ISPH in the ISPC position. Difference traces when the quinone pool
was oxidized (200 mV) or partly reduced (100 mV).
Fig. 1. Rhombicity of the [2Fe–2S] cluster in terms of linear variation of gx
and gy components in the EPR spectra of the Rieske cluster in the bc1
complex, plotted against ( gx gy). The different pairs of points were taken
from published spectra of the ISP from Rb. sphaeroides and Rb. capsulatus
for different mutant strains [19,20,43,44], and different occupancies of the
Qo-site. The linear relationship is predicted by a phenomenological theory
based on the distortion of Fe2 + ligand field [28]. Increasing difference
between gx and gy reflects increased asymmetry.
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available, and includes rise and decay phases for cyt c2 and
c1 and the unseen oxidation of ISPH [9,18,32]:
2Pþ þ c2 þ ISPH:c1f2Pþ cþ2 þ ISPH:cþ1f2Pþ c2
þ ISPox:cþ1 þ Hþ
The ISPH component includes forms in both ISPB and
ISPC positions, and the broad range reflected uncertainty as
to the fraction in these states.
1.5. Thermodynamic aspects
The results of our ESEEM studies provide strong evi-
dence that a H-bonded complex is formed between quinone
and ISPH similar to that seen with stigmatellin. What are the
thermodynamic consequences of this binding? Values for
Em from titrations of the complete bc1 complex with and
without inhibitors are variable, but a number of studies have
been reported in which a change in Em value was measured
on addition of myxothiazol, MOA-stilbene or simple alco-
hols [14,15,33]. In general, for the native bc1 complex,
changes in the range DEm 30–45 mV have been observed,
from Em,7f 265 mV, in the presence, to f 300 mV in the
absence of reagent.
An alternative approach to assaying the Em change on
interaction between quinone and ISPH is through kinetics.
When the ambient redox potential is around the mid-point
for the ISP, the decrease in Em, ISP on addition of myx-
othiazol is expected to lead to a decrease in the fraction of
the reduced ISP, and hence to an increase in amplitude of
cytochrome oxidation as its reductant is lost from the
equilibrium mix. This effect is readily detectable, with an
amplitude consistent with the changes in equilibrium con-
stant calculated from Em values (Fig. 3).
Previous authors have interpreted the change in Em as
reflecting an interaction between the ISP and either the
inhibitor or the protein. However, the structures strongly
suggest that no complex is formed between the ISPH and
myxothiazol or similar inhibitors [2,5,10]; after addition of
inhibitor, almost all ISP initially close to cyt b and the Qo-
site had changed to a position close to cyt c1. In light of the
ESEEM evidence for formation of a H-bonded complex
between quinone and ISPH [31], we propose an alternative
explanation for the Em change. On formation of the complex
with quinone, the Em value of ISP is shifted to a more
positive value by an amount reflecting the binding constant
for the interaction with quinone. This is similar to the
change observed in the complexes of ISPH with UHDBT
or stigmatellin. On addition of myxothiazol, this interaction
is lost, and the ISP shows a lower Em value. If the binding
constant between ISPox and quinone isb1, then the change
in Em gives the binding constant for formation of the
ISPH.Q complex (Kbinding = exp(DEm/RT) 1), with a value
in the range 3–5. From this, the fraction of ISPH complexed
will be in the range 75–85%, consistent with the integrated
area of the gx line, which is similar in the presence of
quinone or stigmatellin (100% occupancy). In relation to the
kinetic data, translation from ISPB to ISPC positions must be
in the range < 30 As, as expected if the reactions of the high
potential chain are much faster than the rate-limiting step
[18]. However, it should be recognized that the kinetic
differences of Fig. 2 also reflect a change in equilibrium
constant for electron transfer from ISPH to cyt c1.
This new interpretation of the myxothiazol-induced
change in apparent Em of ISP is relevant to two recent
reports in the literature.
(i) The Em change induced by alcohols is of interest,
because these reagents also eliminated the sharp gx = 1.80
line characteristic of the H-bond interaction between ISPH
and quinone [33]. An explanation that would account for
Fig. 3. The change in amplitude of cyt ctot oxidation after a single saturating flash following addition of myxothiazol. Left: the kinetics observed at 285 mV
with and without myxothiazol. Right: the dependence of the amplitude of the extra cyt c oxidation as a function of Eh. The data are fit by assuming that the
apparent Em of ISP is 305F 5 mV before and 260F 5 mV after addition of myxothiazol.
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both these effects is that the alcohols compete with ISPH as
H-bond donor to the Qo-site quinone, and thus release the
ISP in its low potential form.
(ii) Darrouzet et al. [15] reported a set of mutants in
which changes in Em of ISP were observed when the linker
region connecting the ISP extrinsic head group to its
anchoring N-terminal segment was changed in length.
Several of these showed quite large changes in apparent
Em (Em,app 355–460 mV) compared to wild-type (f 320
mV), but this effect largely disappeared on addition of
myxothiazol (Em 295F 25 mV for all strains); the myx-
othiazol-induced change was therefore much greater than
the f 40 mV effect discussed above. If the myxothiazol-
induced change reflected only the loss of interaction with
the resident quinone, then a simple interpretation would be
that the linker-length determined the strength of interaction.
The range for DEm values (Em,appEm for the unli-
ganded (myxothiazol) complex) lies between that of the
native complex (f 40 mV), and that of the complex with
stigmatellin (f 240 mV or 23 kJ mol  1), the latter value
being appropriate for the buried H-bond seen in the struc-
tures (bond energies of 20–25 kJ mol1). Since it is relatively
easy to weaken bond strength, but difficult to increase it,
these results suggest the possibility that the native config-
uration is designed to weaken the interaction; the ISP might
be spring-loaded so as to favor the dissociation reaction.
Such a spring-loaded interaction could also apply to the ES-
complex, with obvious mechanistic implications.
1.6. Bypass reactions at the Qo-site in the presence and
absence of oxygen
The reaction of the Qo-site with O2 to produce super-
oxide (SO) has been much studied, and is generally attrib-
uted to one-electron reduction by the intermediate
semiquinone species generated at the site when transfer of
the second electron to the low potential chain is blocked
[33–37]. This occurs on antimycin inhibition or on develop-
ment of a large back-pressure from Dp, with a maximal rate
f 2% of the normal turnover. Several recent observations
have provided new insights to the nature of the reaction.
In mitochondrial complexes, myxothiazol inhibits the
maximal SO production in the presence of antimycin, but
only by about 70%. In the absence of antimycin, production
of SO is stimulated by addition of myxothiazol to give a
similar rate (f 0.6% full turnover) [38,39]. Several groups
have argued convincingly that the reaction involves forma-
tion of semiquinone at the Qo-site [36,39,40]. Since for-
mation of semiquinone depends on oxidation of quinol, this
could occur only if an ES-complex was formed in the
presence of myxothiazol, with occupation of the distal
domain of the site by ubiquinol and reaction with ISPox.
Such a double-occupancy is quite unexpected, since most
data seem to indicate that myxothiazol eliminates all qui-
none species from the site [2,10,41]. Muller et al. [39] found
that, also surprisingly, if the rate of quinol oxidation was
assayed by reduction of cyt c, the bypass rates observed
under anaerobic conditions in the presence of either anti-
mycin or myxothiazol were the same as under aerobic
conditions. This could be explained if generation of semi-
quinone under all conditions was rate-limiting, and inde-
pendent of [O2], and that two pathways competed for the
semiquinone, both with much higher rate constant, one to
O2 and the other indirectly to cyt c. Under aerobic con-
ditions, O2 out-competes the alternative pathway as acceptor
for the second electron. Two plausible candidates for the
alternative pathway were suggested. Most obviously, the
returning ISPox could oxidize the semiquinone after it had
donated the first electron to cyt c via cyt c1. However,
another possibility would involve migration of the semi-
quinone out of the Qo-site to find an adventitious site for
direct reduction of cyt c at the membrane–water interface.
In either case, since the distance from the [2Fe–2S] cluster
in the ISPB position to cyt c1 would preclude direct transfer
from the complexed state [9], the reaction could occur only
if the intermediate ISPH.SQ state dissociated to products.
This shows that the ISPH.SQ state is not so tightly bonded
as to preclude dissociation. A third observation of interest
was that increasing the [O2] fivefold above ambient had no
effect on the rate of SO generation in the presence of
myxothiazol, but stimulated the rate in the presence of
antimycin by f 25%. The saturation at ambient O2 in the
presence of myxothiazol indicates a Km in the range < 20
AM. The relatively high affinity compared to that in the
absence of myxothiazol shows that at least a fraction of the
semiquinone was in a less reactive configuration when the
Qo-site was free of inhibitor.
These observations are open to a number of interpreta-
tions. Although the myxothiazol-insensitive SO production
must indicate some double-occupancy, it is difficult to extend
this to a justification of such a mechanism under normal
turnover. Two features suggest that the 70% inhibition in the
mitochondrial complex must represent a minimal value for
displacement of the distal domain occupant. (i) The [O2]
dependence shows that at least a fraction of the semiquinone
is in a less reactive state in the unoccupied Qo-site. Since the
observed rate will depend on the product of occupancy and
rate constant, if the SQ in the presence of myxothiazol is
hyper-reactive, the occupancy must be proportionately less.
(ii) In Rb. sphaeroides, the antimycin-resistant bypass under
anaerobic conditions was completely inhibited by myxothia-
zol, indicating that the weak double-occupancy is not a
common property of all bc1 complexes (Chen, Y. and Crofts,
A.R., unpublished, and Ref. [42]). A question that must
remain open is the nature of the less reactive SQ species
responsible for the fraction of SO production stimulated by
increasing [O2]. In single occupancy models, this would be
well explained by movement of the SQ deeper into the site to
occupy the myxothiazol-binding domain. In double occu-
pancy models, it would represent distribution of the electron
to a second, less accessible quinone species. The data did not
allow discrimination between these possibilities.
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